Ryan & Maniskas, LLP Announces Investigation of HealthTronics, Inc.

Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/healthtronics) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of HealthTronics, Inc. (“HealthTronics” or the “Company”) (NASDAQ:HTRN) in connection with their actions in causing HealthTronics to enter into a merger agreement with Endo Pharmaceuticals Holdings, Inc. (“Endo”).

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of HealthTronics. For more information regarding our investigation please contact Richard A. Maniskas, Esquire toll-free: [phone] or visit: www.rmclasslaw.com/cases/healthtronics.

Under the proposed agreement, Endo will commence an all cash tender offer to acquire 100 percent of the outstanding shares of HealthTronics for approximately $223 million or $4.85 cash per HealthTronics share plus the assumption of approximately $35 million in net debt. HealthTronics shares that are not acquired in the tender offer will be purchased at the same price in a second-step merger.

If you own shares of HealthTronics and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: [phone] or visit: www.rmclasslaw.com/cases/healthtronics. You may also email Mr. Maniskas at [e-mail]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.